Abstract | OBJECTIVES: We report our experience with polidocanol foam sclerotherapy with no additional coils, evaluating clinical success, patients' satisfaction, and complications. METHODS: We conducted a retrospective study of 141 patients with 146 varicoceles (mean age: 29.3 years; range: 13 - 60 years) who underwent foam sclerotherapy with polidocanol 2% (range: 2 - 12 ml) in an outpatient setting between January 2007 and December 2013. For the follow-up, telephone interviews with the patients were conducted (mean follow-up time: 46.4 months, standard deviation: 20.17 months). RESULTS: The technical success rate was 91.8%. There was a 55.8% response rate to the telephone interviews. Follow-up revealed a clinical success rate of 83.9% and a persistence or relapse rate of 16.1%. Of the patients, 81.9% were absolutely satisfied with the outcome. In 94.9% of cases, pain or discomfort resolution was reported, and in 97% of cases, aesthetic issues were no longer a problem. Of partners, 63.2% achieved pregnancy, and in 50% of patients with preprocedural testicular atrophy, catch-up growth was observed. One patient with pampiniform plexus phlebitis received inpatient treatment with no long-term damage recorded. CONCLUSIONS:
Polidocanol foam varicocele sclerotherapy is a safe and effective procedure, with a high rate of patients' satisfaction, clinical and technical success, and considerable catch-up growth and pregnancy achievement. KEY POINTS: • Varicocele treatment using polidocanol foam sclerotherapy is a safe and effective procedure. • It is easily feasible in an outpatient setting. • The clinical and technical success rates are high. • It shows a high rate of patients' satisfaction and symptom resolution. • Postinterventional catch-up growth and pregnancy achievement are considerable.
|
Authors | Alma Ali, Stefan Wirth, Karla Maria Treitl, Marcus Treitl |
Journal | European radiology
(Eur Radiol)
Vol. 25
Issue 10
Pg. 2889-97
(Oct 2015)
ISSN: 1432-1084 [Electronic] Germany |
PMID | 25796582
(Publication Type: Journal Article, Observational Study)
|
Chemical References |
- Sclerosing Solutions
- Polidocanol
- Polyethylene Glycols
|
Topics |
- Adolescent
- Adult
- Atrophy
(pathology)
- Catheterization
(methods)
- Feasibility Studies
- Humans
- Male
- Middle Aged
- Patient Satisfaction
- Polidocanol
- Polyethylene Glycols
(administration & dosage, adverse effects)
- Recurrence
- Retrospective Studies
- Sclerosing Solutions
(administration & dosage, adverse effects)
- Sclerotherapy
(adverse effects, methods)
- Testis
(pathology)
- Treatment Outcome
- Varicocele
(therapy)
- Young Adult
|